Morten Gjerstorff

17PUBLICATIONS
43CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 26, 2024
Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 5197.

Behzad Mansoori, Mikkel Green Terp, Ali Mohammadi

|Jun 17, 2024
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer.

Sofie Traynor, Mie K Jakobsen, Tina M Green

|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Luca Di Leo, Chiara Pagliuca, Ali Kishk

|Jan 06, 2024
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin

|Dec 23, 2022
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer.

Morten F Gjerstorff, Sofie Traynor, Odd L Gammelgaard

|Sep 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.

Odd L Gammelgaard, Mikkel G Terp, Christian Renn

Pageof 3

Frequent Collaborators

10 joint publications

Henrik Jørn Ditzel

6 joint publications

Behzad Baradaran

6 joint publications

Behzad Mansoori

5 joint publications

Pascal H G Duijf